Cases & Deals

  • Home
  • Practices
  • AstraZeneca prosecutes worldwide patent portfolio licensed from Nektar Therapeutics

Share

AstraZeneca prosecutes worldwide patent portfolio licensed from Nektar Therapeutics

November 2009

Client(s) AstraZeneca LP

Jones Day assisted AstraZeneca LP in worldwide patent prosecution and portfolio management of a patent portfolio licensed from Nektar Therapeutics covering compounds for treating opioid-induced constipation.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.